Medherant

Novel adhesive enabling improved patches for transdermal drug delivery.

Medherant develops innovative transdermal drug delivery products using its proprietary S-PURE adhesive. Transdermal delivery can overcome disadvantages of oral administration, such as spikes in drug levels that cause side effects and gastrointestinal complications. Patches are convenient and can improve compliance The company's lead project is a testosterone patch for women.

Read more

Explore the community

Find out more about who we support through our accelerator programme.

Read more